Omics in Cutaneous Melanoma

Articles in Press

Document Type : Systematic Review and Meta-analysis

Authors

1 Federal State Budgetary Educational Institution of Higher Education “Siberian State Medical University” of the Ministry of Health of the Russian Federation, Tomsk, Tomsk Region, Russia.

2 Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Tomsk Region, Russia.

Abstract

The advancement of multidimensional omics technologies holds immense promise for the future of medical treatment, particularly in addressing a wide range of human illnesses. Melanoma, which ranks among the most aggressive malignant pathologies affecting the skin, is a complex and heterogeneous oncological condition. There exist mutations that are tightly intertwined with the biological behavior of tumors, significantly influencing the course and outcome of the disease. Specifically, a subset of these mutations has been identified as mutually exclusive, involving specific signaling molecules and signaling cascades. Simultaneously, it has now been well established that inactivation of one component can activate alternative signaling pathways, ultimately leading to a more pronounced intensification of carcinogenesis. Consequently, this study not only reveals the impact of transcription factors and growth factors on carcinogenesis, but also emphasizes the importance of non-coding RNA (microRNAs), which constitute a unique set of biomarkers that determine the biological and molecular characteristics of tumors. It is important to note that genomic, transcriptomic, and proteomic profiling of tumors do not provide a complete assessment of their invasive and metastatic potential. The article provides contemporary insights into multimodal approaches for identifying molecular subtypes of melanoma.

Keywords

Main Subjects

Asian Pacific Journal of Cancer Prevention

Articles in Press, Accepted Manuscript
Available Online from 16 October 2025

Files

History

  • Receive Date: 29 December 2024
  • Revise Date: 24 June 2025
  • Accept Date: 09 October 2025

Share

How to cite

Statistics